What is Celiac Disease?
Last reviewed: March 2026
Understanding Celiac Disease
Celiac disease is a serious autoimmune condition in which the ingestion of gluten triggers an immune response that damages the lining of the small intestine. Unlike a food allergy, where the immune system reacts to a protein by producing IgE antibodies, celiac disease involves a different branch of the immune system. When someone with celiac disease eats gluten, a protein found in wheat, barley, and rye, their immune system mistakenly attacks the villi, the tiny finger-like projections that line the small intestine and absorb nutrients. Over time, this damage flattens the villi, leading to malabsorption of essential vitamins and minerals. Celiac disease is not a food sensitivity or a lifestyle choice. It is a genetically mediated autoimmune disorder with potentially serious health consequences if left untreated. The condition can develop at any age, from infancy through late adulthood, and its presentation varies widely from person to person.
How Common is Celiac Disease?
Celiac disease affects approximately 1 in 100 people worldwide, making it one of the most common autoimmune conditions on the planet. In the United States alone, an estimated 3 million people have celiac disease, though studies suggest that roughly 60 to 70 percent of those affected remain undiagnosed. The prevalence has been increasing over the past several decades, and researchers believe this is not solely due to improved detection. Environmental factors, changes in wheat cultivation, shifts in gut microbiome composition, and early childhood feeding practices may all play a role. Celiac disease is more common in people of European descent, but it has been identified in populations across the globe, including in the Middle East, North Africa, India, and parts of Asia. First-degree relatives of someone with celiac disease have a 1 in 10 chance of developing the condition themselves, which is why screening of family members is strongly recommended by gastroenterology guidelines.
Genetic Factors: HLA-DQ2 and HLA-DQ8
Celiac disease has a strong genetic component. Nearly all people with celiac disease carry one or both of two specific genetic markers: HLA-DQ2 and HLA-DQ8. Approximately 95 percent of people with celiac disease carry the HLA-DQ2 gene, while most of the remaining 5 percent carry HLA-DQ8. However, carrying these genes does not mean you will develop celiac disease. About 30 to 40 percent of the general population carries one of these markers, yet only a small fraction of carriers ever develop the condition. This tells researchers that while these genes are necessary for celiac disease to develop, they are not sufficient on their own. An environmental trigger, most commonly a viral infection, physical stress, pregnancy, or surgery, appears to activate the disease in genetically predisposed individuals. Genetic testing can be useful as a rule-out tool: if you do not carry HLA-DQ2 or HLA-DQ8, your chances of having celiac disease are extremely low, less than 1 percent.
Symptoms: More Than Just Digestive Issues
Celiac disease is sometimes called "the great mimicker" because its symptoms are so varied that it is frequently misdiagnosed. Classic gastrointestinal symptoms include chronic diarrhea, bloating, abdominal pain, gas, nausea, and constipation. In children, failure to thrive and delayed growth are common warning signs. However, many people with celiac disease, particularly adults, present primarily with extraintestinal symptoms. These can include iron-deficiency anemia that does not respond to supplementation, chronic fatigue, joint pain, recurrent mouth ulcers (aphthous stomatitis), a specific itchy skin rash called dermatitis herpetiformis, peripheral neuropathy (tingling or numbness in the hands and feet), and unexplained infertility or recurrent miscarriage. Some people have what is called "silent celiac disease," where they have intestinal damage visible on biopsy but report few or no noticeable symptoms. Others may have minimal symptoms that they have grown accustomed to over many years. The wide range of presentations is one reason the average time to diagnosis in the United States has historically been 6 to 10 years from onset of symptoms.
Diagnosis Pathway
Diagnosing celiac disease typically involves a combination of blood tests and an intestinal biopsy. The first step is usually a blood test for tissue transglutaminase IgA antibodies (tTG-IgA), which is the most sensitive and specific screening test available, with a sensitivity and specificity both above 95 percent. If tTG-IgA is elevated, doctors may also check for endomysial antibodies (EMA-IgA) as a confirmatory test. It is critical that patients continue eating gluten during the testing process. Going gluten-free before testing can cause false-negative results because antibody levels drop once gluten is removed from the diet. If blood tests are positive, the next step is an upper endoscopy with biopsies of the duodenum (the first part of the small intestine). Pathologists look for villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes, which together confirm the diagnosis. In some cases, particularly when biopsy results are ambiguous, HLA genetic testing may be used. A negative genetic test effectively rules out celiac disease. Total serum IgA should also be checked, since about 2 to 3 percent of celiac patients have IgA deficiency, which can cause false-negative results on IgA-based antibody tests.
Treatment: The Strict Gluten-Free Diet
Currently, the only effective treatment for celiac disease is a strict, lifelong gluten-free diet. This means completely avoiding all foods and products containing wheat, barley, rye, and their derivatives. Even small amounts of gluten can trigger intestinal damage. The FDA defines "gluten-free" as containing fewer than 20 parts per million (ppm) of gluten, a threshold that research has shown most celiac patients can tolerate without ongoing intestinal damage. Adopting a gluten-free diet requires careful attention to food labels, awareness of hidden sources of gluten (such as soy sauce, malt flavoring, modified food starch, and some medications), and strategies for avoiding cross-contact in the kitchen. Naturally gluten-free grains and starches like rice, corn, quinoa, millet, buckwheat, and certified gluten-free oats can serve as dietary staples. Most people begin to feel better within days to weeks of starting the diet, though complete intestinal healing can take months to years, especially in adults. Working with a registered dietitian who specializes in celiac disease is strongly recommended to ensure nutritional adequacy and to identify hidden sources of gluten.
Complications If Untreated
Left untreated, celiac disease can lead to a range of serious health complications. Chronic malabsorption of calcium and vitamin D increases the risk of osteoporosis and bone fractures, even in young adults. Iron, folate, and vitamin B12 deficiency can cause persistent anemia and neurological problems. Women with untreated celiac disease face higher rates of infertility, recurrent miscarriage, preterm delivery, and low birth weight babies. In children, untreated celiac disease can result in short stature and delayed puberty. One of the most serious long-term risks is an increased likelihood of developing certain cancers, particularly enteropathy-associated T-cell lymphoma (EATL), a rare but aggressive form of intestinal cancer. The risk of lymphoma decreases significantly after several years of strict adherence to a gluten-free diet. Other potential complications include lactose intolerance (due to damage to the intestinal brush border), other autoimmune conditions (people with celiac disease are at higher risk for type 1 diabetes, autoimmune thyroid disease, and autoimmune liver disease), and, in rare cases, a condition called refractory celiac disease, where the intestine does not heal even on a strict gluten-free diet.
Celiac Disease vs. NCGS vs. Wheat Allergy
It is important to distinguish celiac disease from two other gluten-related conditions: non-celiac gluten sensitivity (NCGS) and wheat allergy. Celiac disease is an autoimmune condition with measurable antibodies and observable intestinal damage. NCGS, sometimes called gluten intolerance, causes symptoms similar to celiac disease (bloating, fatigue, headaches, brain fog) but does not produce the same antibodies or cause villous atrophy on biopsy. There is currently no definitive lab test for NCGS; it is diagnosed by excluding celiac disease and wheat allergy, then observing symptom improvement on a gluten-free diet. The prevalence of NCGS is debated, with estimates ranging from 0.5 to 13 percent of the population. Wheat allergy is a true IgE-mediated food allergy, where the immune system produces IgE antibodies against proteins in wheat (not limited to gluten). Wheat allergy can cause rapid-onset symptoms like hives, swelling, difficulty breathing, and in severe cases, anaphylaxis. It is most common in children and is frequently outgrown. A person with wheat allergy may tolerate barley and rye, while a person with celiac disease cannot. All three conditions benefit from avoiding wheat, but the scope of dietary restriction and the medical monitoring required are different for each.
Living Gluten-Free Long Term
Adapting to a gluten-free lifestyle can feel overwhelming at first, but most people find it becomes second nature over time. The key is building reliable routines: learning to read every food label, identifying safe brands and restaurants, and developing a repertoire of meals you enjoy. Many whole foods are naturally gluten-free, including fruits, vegetables, meats, fish, eggs, dairy, legumes, nuts, and seeds. The market for gluten-free specialty products has expanded dramatically, with gluten-free breads, pastas, cereals, and baked goods widely available in most grocery stores. However, it is worth noting that many processed gluten-free products are lower in fiber and higher in sugar and fat compared to their wheat-based counterparts, so building meals around whole foods is generally the healthier approach. Social situations can be challenging. Eating at friends' homes, attending holiday gatherings, and traveling all require planning and communication. Many people with celiac disease find it helpful to bring safe dishes to share at gatherings, carry snacks when traveling, and develop a brief, clear way to explain their needs to hosts and servers without lengthy medical explanations.
Monitoring and Follow-Up
After diagnosis, regular follow-up care is essential to ensure the gluten-free diet is working and to catch any complications early. Most gastroenterologists recommend rechecking tTG-IgA antibody levels 6 to 12 months after starting the diet, with the expectation that levels will normalize as the intestine heals. Persistently elevated antibodies usually indicate ongoing gluten exposure, whether intentional or accidental. A follow-up endoscopy with biopsies may be performed 1 to 2 years after diagnosis to confirm mucosal healing, though practices vary. Routine monitoring should also include screening for nutritional deficiencies (iron, calcium, vitamin D, vitamin B12, folate, zinc), bone density testing (DEXA scan, especially in adults diagnosed later in life), thyroid function tests, and liver function tests. Children should have growth and development tracked closely. Annual visits with a gastroenterologist and a registered dietitian experienced in celiac disease are recommended. It is also important to screen first-degree family members, even if they are asymptomatic, given the high genetic risk.
New Research: Vaccines and Enzyme Therapies
While the gluten-free diet remains the only proven treatment, there is active research into alternative and supplemental therapies. One of the most discussed areas is enzyme therapy. Several companies are developing oral enzymes (glutenases) that could break down gluten in the stomach before it reaches the small intestine. Latiglutenase is the furthest along in clinical trials and has shown some ability to reduce symptoms from accidental gluten exposure, though it is not yet approved and is unlikely to replace the gluten-free diet entirely. Another promising area is vaccine development. Nexvax2, a therapeutic vaccine designed to desensitize the immune system to gluten in HLA-DQ2 positive patients, was the subject of significant attention, though its Phase 2 trial did not meet primary endpoints and development has been restructured. Researchers are also investigating tight junction modulators like larazotide acetate, which aims to reduce intestinal permeability ("leaky gut") and limit gluten peptides from crossing the intestinal barrier. Other research directions include transglutaminase 2 inhibitors, microbiome-based therapies, and nanoparticle-based immune tolerance approaches. While none of these are ready for clinical use yet, the pipeline offers real hope that additional treatment options may become available in the coming years.
Medical Disclaimer: This information is sourced from peer-reviewed medical literature and authoritative health organizations. It is for educational purposes only and should not replace advice from your healthcare provider. Always consult with a board-certified allergist about your specific condition.